Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 56.79% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 428.92% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -39.59% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -4.24% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -30.53% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 90.02% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 186.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 210.36% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -122.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.17% |
| Dec 31, 2025 | -105.57% |
| Sep 30, 2025 | 228.74% |
| Jun 30, 2025 | 425.65% |
| Mar 31, 2025 | 112.83% |
| Dec 31, 2024 | -59.91% |
| Sep 30, 2024 | -119.31% |
| Jun 30, 2024 | -123.82% |
| Mar 31, 2024 | -22.57% |
| Dec 31, 2023 | 60.62% |
| Sep 30, 2023 | 571.96% |
| Jun 30, 2023 | 1,969.47% |
| Mar 31, 2023 | 191.24% |
| Dec 31, 2022 | 2,189.74% |
| Sep 30, 2022 | 198.33% |
| Jun 30, 2022 | -124.74% |
| Mar 31, 2022 | -291.51% |
| Dec 31, 2021 | -95.30% |
| Sep 30, 2021 | -141.33% |
| Jun 30, 2021 | -67.64% |